To say that artificial intelligence (AI) will be a game changer for the life sciences industry is an understatement. Biopharma and medical device companies are using AI and machine learning (ML) to create more effective drugs, make robot-assisted surgeries possible, identify treatment-ready patients, save lives, and so much more. While life sciences companies have used AI for years, the explosive arrival of generative AI tools like ChatGPT and Midjourney in 2023 ignited conversations about how the technology is used. There are some potential risks with AI, including privacy and security, the quality of the data, and the impact these tools will have on the workforce. Despite the risks, the momentum behind AI in life sciences is building fast, and the market is ripe with untapped opportunities.
Read the full article: Artificial Intelligence Is Redefining Life Sciences, but How Can We Get There Faster? //